News
-
-
-
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
Aspire Biopharma to present patent-pending drug delivery tech at Sidoti Virtual Investor Conference on August 20. One-on-one meetings available for investors. Learn about disruptive technology -
-
-
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement
Aspire launches BUZZ BOMB™, a sublingual pre-workout supplement delivering 50mg of caffeine rapidly via new e-commerce site, aiming to enhance performance for fitness enthusiasts. US launch and exclusive offers available -
-
-
-